T

TScan Therapeutics Inc
NASDAQ:TCRX

Watchlist Manager
TScan Therapeutics Inc
NASDAQ:TCRX
Watchlist
Price: 3.1375 USD 5.64%
Market Cap: 167.4m USD
Have any thoughts about
TScan Therapeutics Inc?
Write Note

Cash Flow Statement

Cash Flow Statement
TScan Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(26)
(29)
(34)
(42)
(49)
(57)
(61)
(62)
(66)
(73)
(82)
(88)
(89)
(97)
(104)
(111)
Depreciation & Amortization
1
1
2
3
3
4
5
5
5
5
6
6
5
5
5
5
Stock-Based Compensation
1
1
1
2
3
3
4
4
5
5
5
5
5
6
7
0
Other Non-Cash Items
1
1
1
2
3
3
4
4
5
5
6
6
5
5
6
6
Cash Interest Paid
0
0
0
0
0
0
0
0
0
1
2
2
3
3
3
3
Change in Working Capital
21
18
(3)
(4)
(6)
(9)
(9)
(12)
(10)
(8)
(8)
24
18
19
22
(6)
Cash from Operating Activities
(3)
N/A
(8)
-160%
(34)
-331%
(42)
-23%
(49)
-17%
(59)
-21%
(62)
-5%
(65)
-5%
(67)
-3%
(70)
-5%
(79)
-12%
(54)
+32%
(61)
-14%
(67)
-9%
(71)
-6%
(107)
-50%
Investing Cash Flow
Capital Expenditures
(4)
(6)
(10)
(9)
(10)
(8)
(5)
(5)
(4)
(5)
(3)
(4)
(3)
(3)
(3)
(3)
Other Items
0
0
0
0
0
0
0
0
0
0
0
(60)
(58)
(21)
(54)
(75)
Cash from Investing Activities
(4)
N/A
(6)
-42%
(10)
-60%
(9)
+5%
(10)
-9%
(8)
+24%
(5)
+27%
(5)
+8%
(4)
+16%
(5)
-7%
(3)
+32%
(64)
-1 986%
(61)
+5%
(24)
+61%
(57)
-140%
(78)
-37%
Financing Cash Flow
Net Issuance of Common Stock
0
100
100
190
190
90
90
0
0
0
136
135
135
136
162
163
Net Issuance of Debt
0
0
0
0
0
0
0
29
29
0
0
0
0
0
0
0
Other
0
(0)
(1)
0
0
(1)
0
(0)
(0)
0
0
0
0
0
0
0
Cash from Financing Activities
0
N/A
100
+34 279%
99
-1%
190
+92%
190
+0%
90
-52%
91
+1%
29
-68%
29
0%
29
0%
165
+463%
136
-18%
135
0%
136
+0%
162
+19%
163
+1%
Change in Cash
Net Change in Cash
(7)
N/A
86
N/A
56
-35%
139
+150%
131
-6%
24
-82%
24
+0%
(41)
N/A
(41)
-2%
(45)
-9%
83
N/A
18
-79%
13
-25%
45
+237%
33
-26%
(22)
N/A
Free Cash Flow
Free Cash Flow
(7)
N/A
(14)
-91%
(43)
-213%
(51)
-17%
(59)
-15%
(66)
-13%
(67)
-1%
(70)
-4%
(71)
-1%
(75)
-5%
(82)
-10%
(58)
+29%
(65)
-12%
(70)
-9%
(75)
-7%
(111)
-48%

See Also

Discover More